About this trial
This pilot study evaluated the effectiveness of an AI health education assistant compared to case manager support in hypertension management. Key outcomes included changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP), compliance with health behaviors, 722 goal achievement (monitoring, measurements, lifestyle improvements), and Technology Acceptance Model (TAM) metrics, including perceived usefulness (PU), perceived ease of use (PEU), and behavioral intention (BI). This study aims to examine whether the AI assistant group will achieve greater reductions in systolic and diastolic blood pressure compared to the case manager group. Additionally, it will evaluate whether the AI assistant group will demonstrate higher engagement in 722 goals and greater perceived ease of use. The results of this study are expected to provide further evidence supporting the potential of AI-driven interventions.
Eligibility criteria
Qualifiers
Aged 18 to 75 years at the time of enrollment
Able and willing to provide informed consent
Able to operate a mobile phone and interact with the digital platform
Willing to participate in home blood pressure monitoring
Disqualifiers
Systolic BP consistently <120 mmHg and diastolic BP <70 mmHg, based on baseline home monitoring (considered low BP not targeted in this study)
Pregnant or planning to become pregnant during the study period
Unable to operate a smartphone or digital device independently
Cognitive impairment or language barrier that prevents understanding of study procedures or informed consent
Trial design
Treatments tested in this trial
- Behavioral/Digital Health Intervention
Treatment groups
Locations
Sponsors and collaborators
Taipei Veterans General Hospital, Taiwan
Lead sponsor
Ministry of Health and Welfare, Taiwan
Collaborator